Antimicrobial silver-filled silica nanorattles with low immunotoxicity in dendritic cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 13, Issue 1, 2017, Pages 11-22

  Priebe, Magdalena ^a   Widmer, Jérôme ^a   Suhartha Löwa, Nina ^a   Abram, Sarah Luise ^a   Mottas, Inès ^a   Woischnig, Anne Kathrin ^b   Brunetto, Priscilla S ^a   Khanna, Nina ^b   Bourquin, Carole ^a,c   Fromm, Katharina M ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Antimicrobial properties; Dendritic cells; Immunoresponse; Nanorattles; Silica nanocontainers; Silver nanoparticles

Indexed keywords

BACTERIA; CELLS; COATINGS; CYTOLOGY; ESCHERICHIA COLI; IMMUNE SYSTEM; IMPLANTS (SURGICAL); MEDICAL APPLICATIONS; MICROORGANISMS; SILICA;

ANTI-MICROBIAL PROPERTIES; DENDRITIC CELLS; IMMUNORESPONSE; NANOCONTAINERS; NANORATTLES; SILVER NANOPARTICLES;

SILVER;

ANTIBIOTIC AGENT; INTERLEUKIN 6; SILICA NANOPARTICLE; SILVER; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILICON DIOXIDE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; IMMUNE RESPONSE; IMMUNOTOXICITY; MOUSE; NONHUMAN; SHEEP ERYTHROCYTE; STAPHYLOCOCCUS AUREUS; ANIMAL; CELL CULTURE; CHEMISTRY; DENDRITIC CELL; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; PHAGOCYTOSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; DENDRITIC CELLS; ESCHERICHIA COLI; METAL NANOPARTICLES; MICE; MICROBIAL SENSITIVITY TESTS; PHAGOCYTOSIS; SILICON DIOXIDE; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84995704347     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2016.08.002     Document Type: Article

References (60)

1. 1 Pavithra, D, Doble, M, Biofilm formation, bacterial adhesion and host response on polymeric implants-issues and prevention. Biomed Mater, 3, 2008, 034003.
2. 2 Pye, A, Lockhart, D, Dawson, M, Murray, C, Smith, A, A review of dental implants and infection. J Hosp Infect 72 (2009), 104–110.
3. 3 Nishimura, S, Tsurumoto, T, Yonekura, A, Adachi, K, Shindo, H, Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci 11 (2006), 46–50.
4. 4 Bruellhoff, K, Fiedler, J, Möller, M, Groll, J, Brenner, RE, Surface coating strategies to prevent biofilm formation on implant surfaces. Int J Artif Organs 33 (2010), 646–653.
5. 5 Chopra, I, The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?. J Antimicrob Chemother 59 (2007), 587–590.
6. 6 Chaloupka, K, Malam, Y, Seifalian, AM, Nanosilver as a new generation of nanoproduct in biomedical application. Trends Biotechnol 28 (2010), 580–588.
7. 7 Strydom, SJ, Rose, WE, Otto, DP, Liebenberg, W, de Villiers, MM, Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine: NBM 9 (2013), 85–93.
8. 8 Martinez-Gutierrez, F, Olive, PL, Banuelos, A, Orrantia, E, Nino, N, Morales Sanchez, E, Ruiz, F, Bach, H, Av-Gay, Y, Synthesis, characterization, and evaluation of antimicrobial and cytotoxic effect of silver and titanium nanoparticle. Nanomedicine: NBM 2010:6 (2010), 681–688.
9. 9 Svensson, S, Suska, F, Emanuelsson, L, Palmquist, A, Norlindh, B, Trobos, M, Bäckros, H, Persson, L, Rydja, G, Ohrlander, M, Lyvén, B, Lausmaa, J, Thomsen, P, Osseointegration of titanium with an antimicrobial nanostructured noble metal coating. Nanomedicine: NBM 9 (2013), 1048–1056.
10. 10 Mohanty, S, Mishra, S, Jena, P, Jacob, B, Sarkar, B, Sonawane, A, An investigation of the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles. Nanomedicine: NBM 8 (2012), 916–924.
11. 11 Cavaliere, E, de Cesari, S, Landini, G, Riccobono, E, Pallecchi, L, Rossolini, GM, Gavioli, L, Highly bacterial Ag nanoparticle films obtained by cluster beam deposition. Nanomedicine 11 (2015), 1417–1423.
12. 12 Brandt, O, Mildner, M, Egger, AE, Groessl, M, Rix, U, Posch, M, Keppler, BK, Strupp, C, Mueller, B, Stingl, G, Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver silfadiazine. Nanomedicine 8 (2012), 478–488.
13. 13 Chernousova, S, Epple, M, Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed 52 (2013), 1636–1653.
14. 14 Eckhardt, S, Brunetto, PS, Gagnon, J, Priebe, M, Giese, B, Fromm, KM, Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. Chem Rev 113 (2013), 4708–4754.
15. 15 Spratt, B, Resistance to antibiotics mediated by target alterations. Science 264 (1994), 388–393.
16. 16 Vig Slenters, T, Hauser-Gerspach, I, Daniels, AU, Fromm, KM, Silver coordination compounds as light-stable, nano-structured and anti-bacterial coatings for dental implant and restorative materials. J Mater Chem 18 (2008), 5359–5362.
17. 17 Gordon, O, Vig Slenters, T, Brunetto, PS, Villaruz, AE, Sturdevant, DE, Otto, M, Landmann, R, Fromm, KM, Silver coordination polymers for prevention of implant infection: thiol interaction, impact on respiratory chain enzymes, and hydroxyl radical induction. Antimicrob Agents Chemother 54 (2010), 4208–4218.
18. 18 Brunetto, PS, Vig Slenters, T, Fromm, KM, In vitro biocompatibility of new silver (I) coordination compound coated surfaces for dental implant applications. Materials 4 (2011), 355–367.
19. 19 Kittler, S, Greulich, C, Diendorf, J, Köller, M, Epple, M, Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 22 (2010), 4548–4554.
20. 20 Zhang, W, Yao, Y, Sullivan, N, Chen, Y, Modeling the primary size effects of citrate-coated silver nanoparticles on their ion release kinetics. Environ Sci Technol 45 (2011), 4422–4428.
21. 21 Song, G, Li, C, Hu, J, Zou, R, Xu, K, Han, L, Wang, Q, Yang, J, Chen, Z, Qin, Z, Ruan, K, Hu, R, A simple transformation from silica core-shell-shell to yolk-shell nanostructures: a useful platform for effective cell imaging and drug delivery. J Mater Chem 22 (2012), 17011–17018.
22. 22 Liu, B, Wang, J, Sun, S, Wang, X, Zhao, M, Zhang, W, Zhang, H, Yang, X, A general method for the synthesis of various rattle-type microspheres and their diverse applications. RSC Adv 3 (2013), 18506–18518.
23. 2 hollow mesoporous spheres using colloidal carbon spheres templates. Chem Mater 21 (2009), 2547–2553.
24. 24 Sekhon, BS, Kamboj, SR, Inorganic nanomedicine – part 2. Nanomedicine: NBM 6 (2010), 612–618.
25. 25 Wu, SH, Tseng, CT, Lin, YS, Lin, CH, Hung, Y, Mou, CY, Catalytic nano-rattle of Au@hollow silica: towards a poison-resistant nanocatalyst. J Mater Chem 21 (2010), 789–794.
26. 26 Sun, Y, Duan, L, Guo, Z, DuanMu, Y, Ma, M, Xu, L, Zhang, Y, Gu, N, An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application. J Magn Mater 285 (2005), 65–70.
27. 27 Yazdi, AS, Guarda, G, Riteau, N, Drexler, SK, Tardivel, A, Couillin, I, Tschopp, J, Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. PNAS 107 (2010), 19449–19454.
28. 28 Vandebriel, RJ, Tonk, ECM, de la Fonteyne-Blankestijn, LJ, Gremmer, ER, Verharen, HW, van der Ven, LT, van Loveren, H, de Jong, WH, Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats. Part Fibre Toxicol, 11, 2014, 21.
29. 29 Hosman, AH, van der Mei, HC, Bulstra, SK, Busscher, HJ, Neut, D, Effects of metal-on-metal wear on the host immune system and infection in hip arthroplasty. Acta Orthop 81 (2010), 526–534.
30. 30 Guzman, M, Dille, J, Godet, S, Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine 8 (2012), 35–45.
31. 31 Kim, SW, Jung, JH, Lamsal, K, Kim, YS, Min, JS, Lee, YS, Antifungal effects of silver nanoparticles (AgNPs) against various plant pathogenic fungi. Myconet 40 (2012), 53–58.
32. 32 Xiang, DX, Chen, Q, Pang, L, Zheng, CL, Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. J Virol Methods 178 (2011), 137–142.
33. 3 yolk-shell nanoparticles for simultaneous capture, kill, and removal of pathogen. J Mater Chem 21 (2011), 16344–16348.
34. 34 Priebe, M, Fromm, KM, One-pot synthesis and catalytic properties of encapsulated silver nanoparticles in silica nanocontainers. Part Syst Character 31 (2014), 645–651.
35. 35 National Committee for Clinical Laboratory Standards, Methods for determining bactericidal activity of antimicrobial agents. NCCLS Document M26-A, 1999, PA, National Committee for Clinical Laboratory Standards V.
36. 36 Jin, R, Cao, YW, Mirkin, CA, Kelly, KL, Schatz, GC, Zheng, JG, Photoinduced conversion of silver Nanospheres to Nanoprisms. Science 294 (2001), 1901–1903.
37. 37 Lee, MH, Oh, SG, Suh, KD, Kim, DG, Sohn, D, Preparation of silver nanoparticles in hexagonal phase formed by nonionic Triton X-100 surfactant. Colloids Surf A Physicochem Eng Asp 210 (2002), 49–60.
38. 38 Shirtcliffe, N, Nicle, U, Schneider, S, Reproducible preparation of silver sols with small particle size using borohydride reduction: for use as nuclei for preparation of larger particles. J Colloid Interface Sci 211 (1999), 122–129.
39. 39 van Hyning, DL, Zukoski, C, Formation mechanisms and aggregation behavior of borohydride reduced silver particles. Langmuir 14 (1998), 7034–7046.
40. 40 Zeng, T, Zhang, X, Ma, Y, Wang, S, Niu, H, Cai, Y, A functional rattle-type microsphere with a magnetic-carbon double-layered shell for enhanced extraction of organic targets. Chem Commun 49 (2013), 6039–6041.
41. 2 nanocapsules. J Mater Chem A 1 (2012), 637–643.
42. 42 Liu, A, Wu, L, He, Z, Zhou, J, Development of highly fluorescent silica nanoparticles chemically doped with organic dye for sensitive DNA microarray detection. Anal Bioanal Chem 401 (2011), 2003–2011.
43. 43 Yamaura, M, Camilo, R, Sampaio, L, Macêdo, M, Nakamura, M, Toma, H, Preparation and characterization of (3-aminopropyl) triethoxysilane-coated magnetite nanoparticles. J Magn Mater 279 (2004), 210–217.
44. 44 Sokolova, V, Kozlova, D, Knuschke, T, Buer, J, Westendorf, AM, Epple, M, Mechanism of the uptake of cationic and anionic calcium phosphate nanoparticles by cells. Acta Biomater 9 (2013), 7527–7535.
45. 45 Karlson, TDL, Kong, YY, Hardy, CL, Xiang, SD, Plebanski, M, The signalling imprints of nanoparticle uptake by bone marrow derived dendritic cells. Methods 60 (2013), 275–283.
46. 46 Ahonen, CL, Gibson, SJ, Smith, RM, Pederson, LK, Lindh, JM, Tomai, MA, Vasilakos, JP, Dendritic cell maturation and subsequent enhanced T-cell stimulation induced with the novel synthetic immune response modifier R-848. Cell Immunol 197 (1999), 62–72.
47. 47 Rosenthal, KS, Tan, MJ, Rapid review microbiology and immunology. 2011, Mosby/Elsevier, Philadelphia, PA.
48. 48 Schierholz, J, Beuth, J, Implant infections: a haven for opportunistic bacteria. J Hosp Infect 49 (2001), 87–93.
49. 49 Campoccia, D, Montanaro, L, Arciola, CR, A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 34 (2013), 8533–8554.
50. 50 Klapiszewski, L, Rzemieniecki, T, Krawczyk, M, Malina, D, Norman, M, Zdarta, J, Majchrzak, I, Dobrowolska, A, Czaczyk, K, Jesionowski, T, Kraft lignin/silica-AgNPs as a functional material with antimicrobial activity. Colloids Surf B: Biointerfaces 134 (2015), 220–228.
51. 51 Das, SK, Khan, MR, Parandhaman, T, Laffir, F, Guha, AK, Sekaran, G, Mandal, SB, Nano-silica fabricated with silver nanoparticles: antifouling adsorbent for efficient dye removal, effective water disinfection and biofouling control. Nanoscale 5 (2013), 5549–5560.
52. 52 Parandhaman, T, Das, A, Ramalingam, B, Samanta, D, Sastry, TP, Mandal, AB, Das, SK, Antimicrobial behavior of biosynthesis silica-silver nanocomposite for water disinfection: a mechanistic perspective. J Hazard Mater 290 (2015), 117–126.
53. 53 Schüller, VJ, Heidegger, S, Sandholzer, N, Nickels, PC, Suhartha, NA, Endres, S, Bourquin, C, Liedl, T, Cellular Immunostimulation by CpG-sequence-coated DNA origami structures. ACS Nano 5 (2011), 9696–9702.
54. 54 Heidegger, S, Kirchner, SK, Stephan, N, Bohn, B, Suhartha, N, Hotz, C, Anz, D, Sandholzer, N, Stecher, B, Russmann, H, Endres, S, Bourquin, C, TLR activation excludes circulating naive CD8+ T cells from gut-associated lymphoid organs in mice. J Immunol 190 (2013), 5313–5320.
55. 55 Bourquin, C, von der Borch, P, Zoglmeier, C, Anz, D, Sandholzer, N, Suhartha, N, Wurzenberger, C, Denzel, A, Kammerer, R, Zimmermann, W, Endres, S, Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model. J Immunol 185 (2010), 2580–2588.
56. 56 Li, WR, Xie, XB, Shi, QS, Zeng, HY, Ou-Yang, YS, Chen, YB, Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85 (2010), 1115–1122.
57. 57 Petros, RA, DeSimone, JM, Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9 (2010), 615–627.
58. 58 Monopoli, MP, Aberg, C, Salvati, A, Dawson, KA, Biomolecular coronas provides teh biological indentity of nanosized materials. Nat Nanotechnol 7 (2012), 779–786.
59. 59 Jaganathan, H, Godin, B, Biocompatibility assessment of Si-based nano- and micro-particles. Adv Drug Deliv Rev 64 (2012), 1800–1819.
60. 60 Choi, J, Zhang, Q, Reipa, V, Wang, NS, Stratmeyer, ME, Hitchins, VM, Goering, PL, Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J Appl Toxicol 29 (2009), 52–60.